Population pharmacokinetics (PK) and pharmacodynamics (PD) of vecuronium (V) in critically ill patients

被引:0
|
作者
Rudis, MI
Auclair, B
Zarowitz, BJ
Ducharme, MP
机构
[1] HENRY FORD HOSP,DETROIT,MI 48202
[2] UNIV MONTREAL,FAC PHARM,MONTREAL,PQ H3C 3J7,CANADA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:PI65 / PI65
页数:1
相关论文
共 50 条
  • [1] Variable Pharmacokinetics and Pharmacodynamics (PK/PD) of Piperacillin in Critically Ill Patients
    Akers, Kevin
    Cota, Jason
    Waters, J.
    Chung, Kevin
    Murray, Clinton
    [J]. CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [2] PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF BUMETANIDE (B) IN CRITICALLY ILL CHILDREN
    SULLIVAN, JE
    YAMASHITA, TS
    WELLS, TG
    BLUMER, JL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 180 - 180
  • [3] Lansoprazole suspension pharmacokinetics-pharmacodynamics (PK-PD) in critically ill pediatric patients.
    DiGiacinto, J
    Graumlich, JF
    Bysani, GK
    Torres, A
    Shushunov, S
    Kastrissios, H
    Scheibel, LW
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 104 - 104
  • [4] Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients
    Saito, Jumpei
    Shoji, Kensuke
    Oho, Yusuke
    Kato, Hiroki
    Matsumoto, Shotaro
    Aoki, Satoshi
    Nakamura, Hidefumi
    Ogawa, Takanori
    Hasegawa, Mayumi
    Yamatani, Akimasa
    Miyairi, Isao
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (02)
  • [5] PHARMACOKINETICS AND PHARMACODYNAMICS IN CRITICALLY ILL PATIENTS
    MANN, HJ
    FUHS, DW
    CERRA, FB
    [J]. WORLD JOURNAL OF SURGERY, 1987, 11 (02) : 210 - 217
  • [6] Pharmacokinetics and pharmacodynamics in critically ill patients
    Varghese, Julie M.
    Roberts, Jason A.
    Lipman, Jeffrey
    [J]. CURRENT OPINION IN ANESTHESIOLOGY, 2010, 23 (04) : 472 - 478
  • [7] EFFECTS OF AGE AND DISEASE ON PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF BUMETANIDE (B) IN CRITICALLY ILL INFANTS
    SULLIVAN, JE
    WITTE, MK
    YAMASHITA, TS
    MYERS, C
    BLUMER, JL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 180 - 180
  • [8] PK/PD in critically ill patients
    Scaglione, F.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S2 - S2
  • [9] Population Pharmacokinetics/Pharmacodynamics and Clinical Outcomes of Meropenem in Critically Ill Patients
    Boonpeng, Apinya
    Jaruratanasirikul, Sutep
    Jullangkoon, Monchana
    Samaeng, Maseetoh
    Wattanavijitkul, Thitima
    Bhurayanontachai, Rungsun
    Pattharachayakul, Sutthiporn
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (11)
  • [10] Population pharmacokinetics (PK) pharmacodynamics (PD) of minoxidil (MNX).
    Fadiran, EO
    Miller, R
    Ludden, T
    Karkowsky, A
    Parekh, A
    Ferry, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII46 - PII46